| EIF2AK4-b (GCN2-b) | STE-Unique | STE | 9yak | A | | - | Human | 16226 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1q | B | B | desf-3r/4076 | Human | 12449 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6wpp | A | B | 5-fluoro-n-methyl-2-(7h-pyrrolo[2,3-d]pyrimidin-5-yl)pyrimidin-4-amine | Human | 12736 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idt | A | B | 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine | Human | 2204 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4dn5 | A | | phosphothiophosphoric acid-adenylate ester | Human | 2205 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1t | A | A | 4s/3694 | Human | 12450 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6wpp | A | A | 5-fluoro-n-methyl-2-(7h-pyrrolo[2,3-d]pyrimidin-5-yl)pyrimidin-4-amine | Human | 12737 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idt | B | A | 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine | Human | 2210 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idt | B | B | 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine | Human | 2207 | |
| MAP3K14 (NIK) | STE-Unique | STE | 8yhw | A | | phosphothiophosphoric acid-adenylate ester | Human | 15233 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4g3d | D | | - | Human | 2212 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1t | B | B | 4s/3694 | Human | 12452 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6wpp | B | A | 5-fluoro-n-methyl-2-(7h-pyrrolo[2,3-d]pyrimidin-5-yl)pyrimidin-4-amine | Human | 12738 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idv | A | A | 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1h-indol-5-yl}-2-methylbut-3-yn-2-ol | Human | 2211 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idv | C | A | 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1h-indol-5-yl}-2-methylbut-3-yn-2-ol | Human | 2201 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4dn5 | B | | phosphothiophosphoric acid-adenylate ester | Human | 2202 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4g3d | A | | - | Human | 2208 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4g3d | E | | - | Human | 2214 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1t | B | A | 4s/3694 | Human | 12453 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idv | B | A | 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1h-indol-5-yl}-2-methylbut-3-yn-2-ol | Human | 2206 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1q | A | B | desf-3r/4076 | Human | 12454 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6wpp | B | B | 5-fluoro-n-methyl-2-(7h-pyrrolo[2,3-d]pyrimidin-5-yl)pyrimidin-4-amine | Human | 12739 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idt | A | A | 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine | Human | 2203 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4g3d | B | | - | Human | 2209 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1q | B | A | desf-3r/4076 | Human | 12455 | |
| MAP3K14 (NIK) | STE-Unique | STE | 4idv | D | A | 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1h-indol-5-yl}-2-methylbut-3-yn-2-ol | Human | 2213 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1t | A | B | 4s/3694 | Human | 12456 | |
| MAP3K8 (COT) | STE-Unique | STE | 4y85 | A | | 5-[5-(1h-indol-3-yl)-1h-pyrrolo[2,3-b]pyridin-3-yl]-1,3,4-oxadiazol-2-amine | Human | 427 | |
| MAP3K8 (COT) | STE-Unique | STE | 4y85 | C | | 5-[5-(1h-indol-3-yl)-1h-pyrrolo[2,3-b]pyridin-3-yl]-1,3,4-oxadiazol-2-amine | Human | 424 | |
| MAP3K8 (COT) | STE-Unique | STE | 5iu2 | A | A | n-[2-(morpholin-4-yl)ethyl]-6-(8-phenyl-1h-imidazo[4,5-c][1,7]naphthyridin-1-yl)-1,3-benzothiazol-2-amine | Human | 6980 | |
| MAP3K8 (COT) | STE-Unique | STE | 4y83 | A | | 5-[2-amino-5-(quinolin-3-yl)pyridin-3-yl]-1,3,4-oxadiazole-2(3h)-thione | Human | 428 | |
| MAP3K8 (COT) | STE-Unique | STE | 4y83 | B | | 5-[2-amino-5-(quinolin-3-yl)pyridin-3-yl]-1,3,4-oxadiazole-2(3h)-thione | Human | 426 | |
| MAP3K8 (COT) | STE-Unique | STE | 5iu2 | B | B | n-[2-(morpholin-4-yl)ethyl]-6-(8-phenyl-1h-imidazo[4,5-c][1,7]naphthyridin-1-yl)-1,3-benzothiazol-2-amine | Human | 6978 | |
| MAP3K8 (COT) | STE-Unique | STE | 5iu2 | A | B | n-[2-(morpholin-4-yl)ethyl]-6-(8-phenyl-1h-imidazo[4,5-c][1,7]naphthyridin-1-yl)-1,3-benzothiazol-2-amine | Human | 6981 | |
| MAP3K8 (COT) | STE-Unique | STE | 4y85 | B | | 5-[5-(1h-indol-3-yl)-1h-pyrrolo[2,3-b]pyridin-3-yl]-1,3,4-oxadiazol-2-amine | Human | 429 | |
| MAP3K8 (COT) | STE-Unique | STE | 5iu2 | B | A | n-[2-(morpholin-4-yl)ethyl]-6-(8-phenyl-1h-imidazo[4,5-c][1,7]naphthyridin-1-yl)-1,3-benzothiazol-2-amine | Human | 6979 | |
| MAP3K8 (COT) | STE-Unique | STE | 4y83 | C | | 5-[2-amino-5-(quinolin-3-yl)pyridin-3-yl]-1,3,4-oxadiazole-2(3h)-thione | Human | 425 | |
| MAP3K14 (NIK) | STE-Unique | STE | 6z1q | A | A | desf-3r/4076 | Human | 12451 | |
